Survodutide
Survodutide is a weight management peptide used in evidence-based, physician-supervised protocols. Preferred for patients with fatty liver disease (NASH) or those who did not respond adequately to GLP-1-only agents.
What is Survodutide?
Dual GLP-1/Glucagon receptor agonist (without GIP). Glucagon receptor activation drives hepatic lipid oxidation, thermogenesis, and energy expenditure — particularly effective for NASH/fatty liver. GLP-1R provides satiety and GI slowing. Start 600mcg; titrate to 4.5mg.
Uses & clinical decision logic
Preferred for patients with fatty liver disease (NASH) or those who did not respond adequately to GLP-1-only agents.
Survodutide dosage & administration
| Vial size | BAC water | Dosing range | Units / dose | Frequency | Route |
|---|---|---|---|---|---|
| 10mg | 1mL | 600mcg-4.5mg (titrate) | 6-45 units | 1x/week | SubQ |
Safety & contraindications
Glucagon component can transiently elevate blood glucose — monitor in T2DM. Same class contraindications.
Stacking & combinations
Can add Cagrilintide for amylin-mediated satiety amplification.
Related peptides
Frequently asked questions
What is Survodutide used for?
Preferred for patients with fatty liver disease (NASH) or those who did not respond adequately to GLP-1-only agents.
What is the typical Survodutide dosage?
Common dosing ranges from 600mcg-4.5mg (titrate) (1x/week, SubQ). Exact dosing is individualized and set by a licensed physician.
How is Survodutide administered?
Survodutide is typically administered via SubQ.
What are the contraindications for Survodutide?
Glucagon component can transiently elevate blood glucose — monitor in T2DM. Same class contraindications.
Build a physician-supervised protocol around your goal — no gatekeeping, real doctors, 503A compounding pharmacies.
Build your protocol →This page is for educational purposes only and is not medical advice. Peptide therapies described here are provided under physician supervision through 503A compounding pharmacies. Many peptides are not FDA-approved for the uses described. Do not start, stop, or change any protocol without consulting a licensed physician.